Browse Data and Analysis
Filter
Search Data and Analysis
- 12 results found
- (-) Grains, Feeds and Fodders
- (-) El Salvador
- Clear all
There is no legal impediment to the use of biotechnology in El Salvador. Genetically engineered (GE) corn field trials were successfully completed.
Salvadoran restaurants and hotels continue to benefit from growth in the tourism sector, especially the business/convention and emerging surf sectors.
During 2019, the Salvadoran retail sector, valued at approximately $4.5 billion, continues to show positive signs of growth as supermarkets and discount stores have expanded operations.
Sections Updated: Section II. Purpose of Specific Export Certificate(s) and Section V. Other Certification/Accreditation Requirements.
There is no legal impediment to use of biotechnology. Genetically engineered (GE) corn field trials were successfully completed.
On April 30, 2008, El Salvador abolished Article 30 of the Planting Seed Law that required imported seeds to have a phytosanitary certificate with an additional declaration stating that the seeds....
Sections Updated: Section I. List of all Export Certificates Required by Government and Section II. Purpose of Specific Export Certificate (s), Section V...
Even though there is no legal impediment to use of biotechnology, and genetically engineered (GE) corn field trials have been successfully completed, El Salvador's Ministry of Environment has still...
Since the United States entered into the CAFTA-DR trade agreement, U.S. agricultural exports to the six CAFTA-DR countries have more than doubled.
Central America and the Caribbean, with their close geographical and economic ties to the United States, have always been an important market for U.S. agricultural exports.
In 2008, El Salvador abolished the Planting Seed Law that required imported seeds to have a phytosanitary certificate with an additional declaration stating that the seeds did not contain GMOs.
El Salvador has no legal restriction on the use of agricultural biotechnology. However the country's biotech regulatory framework is still being developed.